<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:55:55Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4355500" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4355500</identifier><datestamp>2015-03-12</datestamp><setSpec>bmcmd</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
      <journal-title-group>
        <journal-title>BMC Medical Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2350</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4355500</article-id>
      <article-id pub-id-type="pmcid">PMC4355500</article-id>
      <article-id pub-id-type="pmc-uid">4355500</article-id>
      <article-id pub-id-type="pmid">25224718</article-id>
      <article-id pub-id-type="pmid">25224718</article-id>
      <article-id pub-id-type="publisher-id">99</article-id>
      <article-id pub-id-type="doi">10.1186/s12881-014-0099-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Exome sequencing identifies a mutation in the <italic>ACTN2</italic> gene in a family with idiopathic ventricular fibrillation, left ventricular noncompaction, and sudden death</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bagnall</surname>
            <given-names>Richard D</given-names>
          </name>
          <address>
            <email>r.bagnall@centenary.org.au</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Molloy</surname>
            <given-names>Laura K</given-names>
          </name>
          <address>
            <email>l.molloy@centenary.org.au</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kalman</surname>
            <given-names>Jonathan M</given-names>
          </name>
          <address>
            <email>Jon.Kalman@mh.org.au</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Semsarian</surname>
            <given-names>Christopher</given-names>
          </name>
          <address>
            <email>c.semsarian@centenary.org.au</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <aff id="Aff1"><label/>Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Locked Bag 6, Newtown, Sydney, NSW 2042 Australia </aff>
        <aff id="Aff2"><label/>Faculty of Medicine, University of Sydney, Sydney, NSW Australia </aff>
        <aff id="Aff3"><label/>Department of Medical Genomics, Royal Prince Alfred Hospital, Sydney, NSW Australia </aff>
        <aff id="Aff4"><label/>Department of Cardiology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria Australia </aff>
        <aff id="Aff5"><label/>Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW Australia </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>99</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© Bagnall et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Potentially lethal and heritable cardiomyopathies and cardiac channelopathies are caused by heterogeneous autosomal dominant mutations in over 50 distinct genes, and multiple genes are responsible for a given disease. Clinical genetic tests are available for several of the inherited cardiac diseases and clinical investigations guide which test to order. This study describes a family with cardiac disease in which marked clinical diversity exists. In the absence of a unified clinical diagnosis, we used exome sequencing to identify a causal mutation.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Clinical evaluation of family members was performed, including physical examination, electrocardiography, 2D transthoracic echocardiography and review of autopsy records. Exome sequencing was performed on a clinically affected individual and co-segregation studies and haplotype analysis were performed to further confirm pathogenicity.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Clinically affected members showed marked cardiac phenotype heterogeneity. While some individuals were asymptomatic, other presentations included left ventricular non-compaction, a resuscitated cardiac arrest due to idiopathic ventricular fibrillation, dilated cardiomyopathy, and sudden unexplained death. Whole exome sequencing identified an Ala119Thr mutation in the alpha-actinin-2 (<italic>ACTN2</italic>) gene that segregated with disease. Haplotype analysis showed that this mutation segregated with an identical haplotype in a second, previously described family with clinically diverse cardiac disease, and is likely inherited from a common ancestor.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Mutations in the <italic>ACTN2</italic> gene can be responsible for marked cardiac phenotype heterogeneity in families. The diverse mechanistic roles of ACTN2 in the cardiac Z-disc may explain this heterogeneous clinical presentation. Exome sequencing is a useful adjunct to cardiac genetic testing in families with mixed clinical presentations.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12881-014-0099-0) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Phenotype heterogeneity</kwd>
        <kwd>Arrhythmia</kwd>
        <kwd>Cardiomyopathy</kwd>
        <kwd>Exome sequencing</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Concerted effort over the past two decades has identified over 50 distinct genes that cause potentially lethal and heritable cardiomyopathies and primary arrhythmogenic disorders. For most of these disorders, there are multiple disease-associated genes [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>]. Furthermore, mutations in a single gene can cause different diseases, e.g. mutations in the myosin heavy chain 7 <italic>(MYH7)</italic> gene cause hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy and dilated cardiomyopathy (DCM) [<xref ref-type="bibr" rid="CR3">3</xref>-<xref ref-type="bibr" rid="CR5">5</xref>], while mutations in the sodium channel, type V, alpha subunit <italic>(SCN5A)</italic> gene cause long QT syndrome (LQTS) and Brugada syndrome [<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref>]. Even within families harbouring the same mutation, incomplete penetrance, phenotype heterogeneity and a variable risk of adverse outcomes are common. In spite of the low genotype-phenotype correlation in the cardiomyopathies and cardiac channelopathies, recent guidelines and expert opinion recommend genetic testing on index cases with a sound clinical suspicion for disease [<xref ref-type="bibr" rid="CR8">8</xref>], as a genetic diagnosis can explain why the disease has occurred, and allows predictive testing of other asymptomatic at-risk family members.</p>
      <p>Commercial genetic tests are available for several of the inherited cardiac diseases, and clinical evaluations guide which test to order. Typically, only the genes most frequently associated with a given disease are screened for mutations. However, advances in targeted massively parallel sequencing, or next-generation sequencing, have overcome the limitations of traditional direct DNA sequencing, and ever-expanding panels of genes are available for screening, including all of the protein-coding genes, i.e. the exome [<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref>],</p>
      <p>This study describes the clinical and genetic investigations of an Australian family with marked cardiac phenotype heterogeneity among four individuals, including left ventricular non-compaction (LVNC), idiopathic ventricular fibrillation, DCM and sudden unexplained death, which lent itself to the application of exome sequencing to identify a pathogenic mutation.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Clinical evaluation of family members</title>
        <p>Clinical evaluation of family members was performed at the Genetic Heart Diseases Clinic at Royal Prince Alfred Hospital, Sydney, and Melbourne Heart Centre, The Royal Melbourne Hospital, Parkville, Australia, with written informed consent and in accordance with the local human ethics standards. Clinical evaluation included detailed personal and family histories, physical examination, transthoracic echocardiography, 12-lead electrocardiogram (ECG) recording, cardiac magnetic resonance imaging (MRI), 24-hour Holter monitoring, exercise testing and review of medical records and autopsy reports.</p>
      </sec>
      <sec id="Sec4">
        <title>Exome sequencing</title>
        <p>Genomic DNA was extracted from buffy coat using a QIAmp DNA blood mini kit (Qiagen, Limburg, NL), according to manufacturerâs recommendations. An adaptor-ligated DNA sequencing library was prepared, enriched for the Illumina TruSeq Exome, and paired-end sequenced using an Illumina HiSeq2000 (Macrogen Facility, Seoul, Korea). The 101Â bp sequences were aligned to the human genome sequence (GRCh37/hg19) using BWA v0.7.4 [<xref ref-type="bibr" rid="CR11">11</xref>] with the default parameters. Sequence alignment files were sorted, converted to binary format and indexed using SamTools v0.1.19 [<xref ref-type="bibr" rid="CR12">12</xref>], and duplicate reads were removed using Picard tools v1.81 (<ext-link ext-link-type="uri" xlink:href="http://picard.sourceforge.net/index.shtml">http://picard.sourceforge.net/index.shtml</ext-link>). The Genome Analysis Tool Kit v2.7.2 [<xref ref-type="bibr" rid="CR13">13</xref>] (GATK) was used for read realignment around insertions/deletions, base quality score recalibration and genotyping of simple nucleotide variations (SNVs) and short insertions and deletions (InDels) using UnifiedGenotyper, according to the GATK best practices (<ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/gatk/guide/best-practices">http://www.broadinstitute.org/gatk/guide/best-practices</ext-link>). SNVs and InDels were annotated using SeattleSeq Annotation tool v8.07 (<ext-link ext-link-type="uri" xlink:href="http://snp.gs.washington.edu/SeattleSeqAnnotation137/index.jsp">http://snp.gs.washington.edu/SeattleSeqAnnotation137/index.jsp</ext-link>) and compared against the November 2010 release of the 1000 Genomes Project data (<ext-link ext-link-type="uri" xlink:href="http://www.1000genomes.org/">http://www.1000genomes.org/</ext-link>), the National Heart, Lung and Blood Institute Exome Sequencing Project (ESP) data (<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/evs_bulk_data/ESP6500SI-V2-SSA137.GRCh38-liftover.snps_indels.txt.tar.gz">http://evs.gs.washington.edu/evs_bulk_data/ESP6500SI-V2-SSA137.GRCh38-liftover.snps_indels.txt.tar.gz</ext-link>) and in-house exome sequences of 96 unrelated individuals using custom Perl scripts. Estimates of gene expression levels (FKPM) in cardiac tissue were determined with a custom built RNASeq analysis pipeline using data from Illuminaâs Human BodyMap 2.0 project (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR030/ERR030886/ERR030886_1.fastq.gz">ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR030/ERR030886/ERR030886_1.fastq.gz</ext-link>; <ext-link ext-link-type="uri" xlink:href="ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR030/ERR030886/ERR030886_2.fastq.gz">ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR030/ERR030886/ERR030886_2.fastq.gz</ext-link>).</p>
      </sec>
      <sec id="Sec5">
        <title>Variant validation using Sanger sequencing</title>
        <p>For validation of detected variants, genomic regions up to 500Â bp surrounding variants of interest were PCR amplified, excess primers and deoxynucleotide triphosphates removed using alkaline phosphatase (New England Biolabs, MA, USA) and exonuclease I (New England Biolabs), respectively, and Sanger DNA sequenced (Macrogen). Sequencing electropherograms were manually inspected using Sequencher v5.1 (Gene Codes Corp, MI, USA).</p>
      </sec>
      <sec id="Sec6">
        <title>Haplotype analysis</title>
        <p>Primer sequences were designed, with a 6-FAM fluorophore on the reverse primer, to PCR amplify a variable number of tandem repeat (VNTR) polymorphism in alpha-actinin 2 (<italic>ACTN2</italic>), and ryanodine receptor 2 (<italic>RYR2</italic>), plus markers D1S2670, D1S285 and D1S2678 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>). PCR was performed at 95Â°C for 2Â minutes, followed by 30Â cycles of 95Â°C for 30Â seconds, 54Â°C for 30Â seconds and 72Â°C for 30Â seconds, followed by a final extension at 72Â°C for 5Â minutes. PCR amplicons were separated on an ABI 3730xl DNA analyser (Macrogen) with GeneScanâ¢ 500 LIZâ¢ size standard (Life Technologies, CA, USA) and alleles sized using Peak Scanner<sup>TM</sup> software v1.0 (Life Technologies).</p>
        <p>All studies were conducted with strict approval and in accordance with the Sydney Local Health District Ethics Review Committee (RPAH zone), Australia.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="results">
      <title>Results</title>
      <sec id="Sec8">
        <title>Clinical characterisation of family ALB</title>
        <p>The clinical characteristics of family ALB are summarised in TableÂ <xref rid="Tab1" ref-type="table">1</xref> and the pedigree illustrated in FigureÂ <xref rid="Fig1" ref-type="fig">1</xref>. The family demonstrates marked clinical heterogeneity. The female proband (III:5) presented at age 22Â years for clinical screening with a history of syncope and a family history of premature sudden unexplained death. Her sister (III:6) died suddenly during sleep at age 25Â years, and her post-mortem failed to identify a cause of death. The probandâs ECG showed sinus rhythm with non-specific ST-T wave changes, whilst her echocardiogram and MRI showed prominent left ventricular apical trabeculations with preserved left ventricular systolic function, consistent with LVNC (FigureÂ <xref rid="Fig2" ref-type="fig">2</xref>). There were no inducible arrhythmias during an electrophysiological study, and her QTc measured 440Â ms. An implantable cardioverter defibrillator (ICD) was subsequently implanted and she remains stable, with no ICD discharges to date.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Clinical characteristics in family ALB</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>ID</bold>
</th><th>
<bold>Gender</bold>
</th><th>
<bold>Current age (yrs)</bold>
</th><th>
<bold>Age at echo (yrs)</bold>
</th><th>
<bold>LVmax (mm)</bold>
</th><th>
<bold>PW (mm)</bold>
</th><th>
<bold>LVEDD (mm)</bold>
</th><th>
<bold>EF (%)</bold>
</th><th>
<bold>ECG</bold>
</th><th>
<bold>ICD</bold>
</th><th>
<bold>Appropriate ICD shocks</bold>
</th><th>
<bold>Final diagnosis</bold>
</th></tr></thead><tbody><tr valign="top"><td align="left">II-3</td><td align="left">M</td><td align="left">Deceased</td><td align="left">60</td><td align="left">12</td><td align="left">12</td><td align="left">58</td><td align="left">27</td><td align="left">LBBB</td><td align="left">No</td><td align="left">NA</td><td align="left">DCM</td></tr><tr valign="top"><td align="left">III-2</td><td align="left">F</td><td align="left">35</td><td align="left">29</td><td align="left">6</td><td align="left">6</td><td align="left">51</td><td align="left">N</td><td align="left">Normal</td><td align="left">No</td><td align="left">NA</td><td align="left">Normal</td></tr><tr valign="top"><td align="left">III-3</td><td align="left">F</td><td align="left">33</td><td align="left">27</td><td align="left">6</td><td align="left">6</td><td align="left">49</td><td align="left">N</td><td align="left">Minor T-wave changes</td><td align="left">Yes</td><td align="left">2</td><td align="left">IVF (RCA)</td></tr><tr valign="top"><td align="left">III-5</td><td align="left">F</td><td align="left">35</td><td align="left">34</td><td align="left">6</td><td align="left">4</td><td align="left">51</td><td align="left">N</td><td align="left">ST-T wave changes</td><td align="left">Yes</td><td align="left">0</td><td align="left">LVNC</td></tr><tr valign="top"><td align="left">III-6</td><td align="left">F</td><td align="left">Died 25</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">No</td><td align="left">NA</td><td align="left">SUDY</td></tr></tbody></table><table-wrap-foot><p>LVmax - maximum left ventricular wall thickness; PW - posterior wall thickness; LVEDD â left ventricular end-diastolic diameter; EF â ejection fraction; ICD â implantable cardioverter-defibrillator; ECG â electrocardiogram; LBBB â left bundle branch block; DCM â dilated cardiomyopathy; RCA â resuscitated cardiac arrest; IVF â idiopathic ventricular fibrillation; LVNC â left ventricular non-compaction; SUDY â sudden unexplained death in the young; N â normal; NA â not applicable.</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>ALB Family Pedigree. </bold>Squares - males; Circles - females; Line through symbol â deceased individual; open symbol with N â clinically unaffected individual; LVNC - left ventricular non-compaction; VF â ventricular fibrillation; DCM â dilated cardiomyopathy; SUD â sudden unexplained death.</p></caption><graphic xlink:href="12881_2014_99_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>ECG and echocardiographic features of the proband (III:5).</bold> The ECG <bold>(A)</bold> shows minimal pathological changes, while the echocardiogram shows <bold>(B)</bold> LVNC predominantly affecting the left ventricular apex (arrowed) and <bold>(C)</bold> colour Doppler flow between the trabeculations.</p></caption><graphic xlink:href="12881_2014_99_Fig2_HTML" id="MO2"/></fig></p>
        <p>The probandâs father (II:3) had a history of dyspnoea, left bundle branch block and left ventricular dilatation, with a reduced left ventricular ejection fraction of 27%. The cause of his DCM remained unclear. One female cousin of the proband (III:3) experienced a resuscitated out of hospital cardiac arrest. MRI revealed normal left and right ventricular indexed dimensions and function, with no evidence of myocardial fibrosis, and no features of cardiomyopathy. She was found to have idiopathic ventricular fibrillation and an ICD was implanted, which has subsequently delivered two appropriate shocks (FigureÂ <xref rid="Fig3" ref-type="fig">3</xref>). She has responded successfully to quinidine therapy. Her sister (III:2), age 29Â years, has been repeatedly evaluated and all cardiovascular investigations have been normal, including a normal ECG, echocardiogram, electrophysiological study and a 7-day Holter monitor. Clinical data, including cardiac screening results, were not available for the probandâs grandparents (I:I and I:2) and uncle (II:1).<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Ventricular fibrillation in relative III:3.</bold> Example of a short coupled ventricular ectopic triggering VF, as is typically seen in idiopathic ventricular fibrillation.</p></caption><graphic xlink:href="12881_2014_99_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec9">
        <title>Exome sequencing</title>
        <p>To identify a pathogenic mutation responsible for the cardiac phenotype in family ALB, exome sequencing was performed on the probandâs DNA. 62,859,256 sequence reads of 101Â bp were generated, of which 38,964,387 mapped uniquely to target regions, representing an average exome-wide coverage of 50.7 reads, with 82.2% of target bases covered at least 20 times. 44,508 SNVs and 4,837 InDels were identified across the 62Â Mb target exome, of which 8,214 SNVs caused a non-synonymous, splice-site or nonsense change and 410 InDels occurred in the coding regions or splice signal sequences. We excluded all homozygous variants and heterozygous variants present at &gt;1% frequency in any ethnic subgroup of the 1000 Genomes Project data, or in 6500 exomes of ESP, leaving 259 rare non-synonymous, splice site and nonsense SNVs in 250 genes (Additional file <xref rid="MOESM2" ref-type="media">2</xref>) and 13 rare in-frame, frameshift and splice site InDels in 13 genes (Additional file <xref rid="MOESM3" ref-type="media">3</xref>). Genes were sorted by expression level in cardiac tissue, derived from RNAseq data, which ranked <italic>ACTN2</italic> Ala119Thr non-synonymous variation as number 1; the top 20 ranked variations are shown in TableÂ <xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Ranked cardiac expressed exome variants identified</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>Chr</bold>
</th><th>
<bold>Nucleotide</bold>
</th><th>
<bold>Ref base</bold>
</th><th>
<bold>Alt base</bold>
</th><th>
<bold>Gene symbol</bold>
</th><th>
<bold>Gene name</bold>
</th><th>
<bold>Cardiac expression (FKPM)</bold>
</th><th>
<bold>Amino acid replacement</bold>
</th><th>
<bold>rs SNP ID</bold>
</th><th>
<bold>ESP6500 alleles</bold>
</th><th>
<bold>1 K Genomes allele frequency</bold>
</th><th>
<bold>GERP score</bold>
</th><th>
<bold>Grantham score</bold>
</th><th>
<bold>PolyPhen score</bold>
</th></tr></thead><tbody><tr valign="top"><td align="left">
<bold>1</bold>
</td><td align="left">
<bold>236882307</bold>
</td><td align="left">
<bold>G</bold>
</td><td align="left">
<bold>A</bold>
</td><td align="left">
<bold>ACTN2</bold>
</td><td>
<bold>Actinin, alpha 2</bold>
</td><td align="left">
<bold>581.019</bold>
</td><td align="left">
<bold>Ala119Thr</bold>
</td><td align="left">
<bold>0</bold>
</td><td align="left">
<bold>G = 13006</bold>
</td><td align="left">
<bold>0</bold>
</td><td align="left">
<bold>5.56</bold>
</td><td align="left">
<bold>58</bold>
</td><td align="left">
<bold>0.999</bold>
</td></tr><tr valign="top"><td align="left">
<bold>12</bold>
</td><td align="left">
<bold>33049590</bold>
</td><td align="left">
<bold>C</bold>
</td><td align="left">
<bold>T</bold>
</td><td align="left">
<bold>PKP2</bold>
</td><td>
<bold>Plakophilin 2</bold>
</td><td align="left">
<bold>257.408</bold>
</td><td align="left">
<bold>Asp26Asn</bold>
</td><td align="left">
<bold>143004808</bold>
</td><td align="left">
<bold>T = 60/C = 12284</bold>
</td><td align="left">
<bold>0.0027</bold>
</td><td align="left">
<bold>4.07</bold>
</td><td align="left">
<bold>23</bold>
</td><td align="left">
<bold>0.992</bold>
</td></tr><tr valign="top"><td align="left">3</td><td align="left">49158893</td><td align="left">C</td><td align="left">T</td><td align="left">LAMB2</td><td>Laminin, beta 2</td><td align="left">241.959</td><td align="left">Ala1745Thr</td><td align="left">142041381</td><td align="left">T = 5/C = 13001</td><td align="left">0</td><td align="left">5.34</td><td align="left">58</td><td align="left">1</td></tr><tr valign="top"><td align="left">20</td><td align="left">6012009</td><td align="left">C</td><td align="left">T</td><td align="left">CRLS1</td><td>Cardiolipin synthase 1</td><td align="left">54.3269</td><td align="left">Pro119Leu</td><td align="left">0</td><td align="left">C = 13004</td><td align="left">0</td><td align="left">5.83</td><td align="left">98</td><td align="left">0.996</td></tr><tr valign="top"><td align="left">6</td><td align="left">138428407</td><td align="left">G</td><td align="left">A</td><td align="left">PERP</td><td>TP53 apoptosis effector</td><td align="left">50.2039</td><td align="left">Ala24Val</td><td align="left">0</td><td align="left">G = 12832</td><td align="left">0</td><td align="left">â2.97</td><td align="left">64</td><td align="left">0</td></tr><tr valign="top"><td align="left">X</td><td align="left">32509625</td><td align="left">A</td><td align="left">C</td><td align="left">DMD</td><td>Dystrophin</td><td align="left">41.8677</td><td align="left">Asn789Lys</td><td align="left">72468681</td><td align="left">C = 63/A = 10498</td><td align="left">0.01</td><td align="left">0.181</td><td align="left">94</td><td align="left">0.856</td></tr><tr valign="top"><td align="left">10</td><td align="left">81109459</td><td align="left">G</td><td align="left">C</td><td align="left">PPIF</td><td>Peptidylprolyl isomerase F</td><td align="left">40.9854</td><td align="left">Gly89Arg</td><td align="left">145899672</td><td align="left">A = 3/G = 13003</td><td align="left">0</td><td align="left">5.4</td><td align="left">125</td><td align="left">1</td></tr><tr valign="top"><td align="left">2</td><td align="left">44200942</td><td align="left">T</td><td align="left">C</td><td align="left">LRPPRC</td><td>Leucine-rich pentatricopeptide repeat containing</td><td align="left">35.1996</td><td align="left">Asn418Ser</td><td align="left">0</td><td align="left">C = 1/T = 13005</td><td align="left">0</td><td align="left">2.14</td><td align="left">46</td><td align="left">0.199</td></tr><tr valign="top"><td align="left">19</td><td align="left">11617100</td><td align="left">C</td><td align="left">T</td><td align="left">ECSIT</td><td>ECSIT homolog</td><td align="left">26.5929</td><td align="left">Glu185Lys</td><td align="left">0</td><td align="left">C = 12994</td><td align="left">0</td><td align="left">5.4</td><td align="left">56</td><td align="left">0.999</td></tr><tr valign="top"><td align="left">19</td><td align="left">11623977</td><td align="left">T</td><td align="left">C</td><td align="left">ECSIT</td><td>ECSIT homolog</td><td align="left">26.5929</td><td align="left">Asn211Ser</td><td align="left">202141211</td><td align="left">T = 13006</td><td align="left">0</td><td align="left">4.94</td><td align="left">46</td><td align="left">1</td></tr><tr valign="top"><td align="left">
<bold>3</bold>
</td><td align="left">
<bold>38645378</bold>
</td><td align="left">
<bold>G</bold>
</td><td align="left">
<bold>T</bold>
</td><td align="left">
<bold>SCN5A</bold>
</td><td>
<bold>Sodium channel, type V, alpha subunit</bold>
</td><td align="left">
<bold>26.2725</bold>
</td><td align="left">
<bold>Ala572Asp</bold>
</td><td align="left">
<bold>36210423</bold>
</td><td align="left">
<bold>T = 21/G = 12443</bold>
</td><td align="left">
<bold>0</bold>
</td><td align="left">
<bold>3.19</bold>
</td><td align="left">
<bold>126</bold>
</td><td align="left">
<bold>0.116</bold>
</td></tr><tr valign="top"><td align="left">19</td><td align="left">48257869</td><td align="left">C</td><td align="left">T</td><td align="left">GLTSCR2</td><td>Glioma tumor suppressor candidate region gene 2</td><td align="left">25.0259</td><td align="left">Thr284Met</td><td align="left">200463741</td><td align="left">T = 58/C = 12146</td><td align="left">0.0027</td><td align="left">1.65</td><td align="left">81</td><td align="left">0.927</td></tr><tr valign="top"><td align="left">3</td><td align="left">33633938</td><td align="left">T</td><td align="left">C</td><td align="left">CLASP2</td><td>Cytoplasmic linker associated protein 2</td><td align="left">21.537</td><td align="left">Lys440Glu</td><td align="left">0</td><td align="left">T = 11976</td><td align="left">0</td><td align="left">5.68</td><td align="left">56</td><td align="left">0.525</td></tr><tr valign="top"><td align="left">9</td><td align="left">131341997</td><td align="left">T</td><td align="left">G</td><td align="left">SPTAN1</td><td>Spectrin, alpha, non-erythrocytic 1</td><td align="left">21.2749</td><td align="left">Ser435Ala</td><td align="left">144787939</td><td align="left">G = 26/T = 12980</td><td align="left">0</td><td align="left">5.35</td><td align="left">99</td><td align="left">0.614</td></tr><tr valign="top"><td align="left">2</td><td align="left">238280543</td><td align="left">C</td><td align="left">T</td><td align="left">COL6A3</td><td>Collagen, type VI, alpha 3</td><td align="left">21.1203</td><td align="left">Ala1373Thr</td><td align="left">112181324</td><td align="left">T = 12/C = 12994</td><td align="left">0.0018</td><td align="left">â0.587</td><td align="left">58</td><td align="left">0.635</td></tr><tr valign="top"><td align="left">5</td><td align="left">122135444</td><td align="left">A</td><td align="left">G</td><td align="left">SNX2</td><td>Sorting nexin 2</td><td align="left">20.0545</td><td align="left">Glu95Gly</td><td align="left">141745241</td><td align="left">G = 6/A = 13000</td><td align="left">0</td><td align="left">5.25</td><td align="left">98</td><td align="left">0</td></tr><tr valign="top"><td align="left">5</td><td align="left">57755609</td><td align="left">G</td><td align="left">C</td><td align="left">PLK2</td><td>Polo-like kinase 2</td><td align="left">19.4331</td><td align="left">His60Asp</td><td align="left">140600076</td><td align="left">C = 14/G = 12940</td><td align="left">0</td><td align="left">5.26</td><td align="left">81</td><td align="left">0.008</td></tr><tr valign="top"><td align="left">9</td><td align="left">140006432</td><td align="left">A</td><td align="left">G</td><td align="left">DPP7</td><td>Dipeptidyl-peptidase 7</td><td align="left">18.8162</td><td align="left">Met367Thr</td><td align="left">78671427</td><td align="left">G = 47/A = 12959</td><td align="left">0.0018</td><td align="left">3.97</td><td align="left">81</td><td align="left">0.946</td></tr><tr valign="top"><td align="left">2</td><td align="left">39509689</td><td align="left">T</td><td align="left">C</td><td align="left">MAP4K3</td><td>Mitogen-activated protein kinase 3</td><td align="left">18.6804</td><td align="left">Ile511Val</td><td align="left">78142399</td><td align="left">C = 57/T = 12949</td><td align="left">0.0014</td><td align="left">5.21</td><td align="left">29</td><td align="left">0.007</td></tr><tr valign="top"><td align="left">6</td><td align="left">31600314</td><td align="left">G</td><td align="left">C</td><td align="left">PRRC2A</td><td>Proline-rich coiled-coil 2A</td><td align="left">18.6379</td><td align="left">Glu1288Asp</td><td align="left">0</td><td align="left">G = 8436</td><td align="left">0</td><td align="left">â2.26</td><td align="left">45</td><td align="left">0</td></tr></tbody></table><table-wrap-foot><p>NB: Genes associated with a primary cardiac phenotype are shown bold.</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec10">
        <title>Genotyping and haplotype analysis</title>
        <p>Three non-synonymous variants in cardiac disease-associated genes were selected for co-segregation analysis in family members as they affected conserved residues in genes associated with primary cardiac pathologies: Ala119Thr in <italic>ACTN2</italic>, previously reported in a family with heterogeneous HCM [<xref ref-type="bibr" rid="CR14">14</xref>], Ala572Asp in <italic>SCN5A</italic> (rs36210423), and Asp26Asn in plakophillin 2 <italic>(PKP2)</italic> (rs143004808). Sanger DNA sequencing confirmed the presence of each variant in the probandâs DNA, however, only Ala119Thr in <italic>ACTN2</italic> co-segregated with disease in all of the affected family members, and was also present in one clinically unaffected female (III:2; FigureÂ <xref rid="Fig4" ref-type="fig">4</xref>A, B).<fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>Genotyping and haplotype analysis in ALB and EI families. (A)</bold> Haplotype analysis in the current Family ALB, <bold>(B)</bold> DNA sequences of the haplotype, and <bold>(C)</bold> haplotype analysis in previous Family EI. *inferred haplotype.</p></caption><graphic xlink:href="12881_2014_99_Fig4_HTML" id="MO4"/></fig></p>
        <p>Since we had previously identified the <italic>ACTN2</italic> Ala119Thr variant in an apparently unrelated Australian family with clinically heterogeneous HCM [<xref ref-type="bibr" rid="CR14">14</xref>], we performed haplotype analysis to determine if the variant segregates on the same haplotype in both families. Five VNTRs spanning a 2.9Â Mb region around <italic>ACTN2</italic> were selected; D1S2850 and D1S2670, as used in our previous study, plus one VNTR each in <italic>ACTN2</italic> and <italic>RYR2</italic>, and D1S2678. Haplotype analysis revealed that the Ala119Thr variant segregates with a unique haplotype common to both families, defined by allele sizes of 259Â bp in D1S2678, 155Â bp in D1S2850, 142Â bp in the <italic>ACTN2</italic> VNTR, 193Â bp in the <italic>RYR2</italic> VNTR and 118Â bp in D1S2670 (FigureÂ <xref rid="Fig4" ref-type="fig">4</xref>A, C). We previously determined that the Ala119Thr variant was absent in 297 unrelated probands with HCM, however, since LVNC was a feature in both ALB and EI families, we genotyped a panel of 31 unrelated patients with LVNC. The Ala119Thr variant was absent in all samples (not shown).</p>
      </sec>
    </sec>
    <sec id="Sec11" sec-type="discussion">
      <title>Discussion</title>
      <p>Clinical evaluation of an Australian family revealed diverse cardiac pathologies in four affected members and genetic testing of the exome identified a pathogenic <italic>ACTN2</italic> heterozygous variant (Ala119Thr) that co-segregated with disease. The variant affects an amino acid in the highly conserved actin-binding CH1 domain [<xref ref-type="bibr" rid="CR14">14</xref>]. The diverse clinical phenotypes seen in this family, including idiopathic ventricular fibrillation, LVNC, and sudden unexplained death, suggest mutations in the <italic>ACTN2</italic> gene likely perturb a number of different mechanical and arrhythmogenic substrates. In families with such variable clinical presentations, a non-biased whole exome sequencing approach may be useful in elucidating the underlying genetic cause of disease.</p>
      <p>We previously identified the same novel mutation as the cause of a marked clinically heterogeneous cardiac phenotype in a 3 generation family with 27 members (EI family) using genome-wide linkage analysis [<xref ref-type="bibr" rid="CR14">14</xref>]. The Ala119Thr mutation is absent from 260 control samples, 6500 ESP exomes and the 1000 Genomes data, and segregates with the same unique haplotype in the ALB and EI families. The variant segregates with all affected members of both families (n = 11). Collectively this further validates the pathogenicity of the Ala119Thr mutation in <italic>ACTN2</italic>, which is likely inherited from a common ancestor of both families.</p>
      <p>The diversity of clinical phenotypes is a major fascination both in the current (ALB) and our previously reported (EI) families. The spectrum of clinical presentations and clinical outcomes is remarkably similar in both families, and includes both structural and arrhythmogenic pathologies. Several individuals have either hypertrophic cardiomyopathy (both classical and apical forms) or isolated LVNC. Cardiac arrhythmogenic abnormalities, including atrial and ventricular fibrillation, resuscitated cardiac arrest, and appropriate ICD discharges have been reported in a number of individuals in both families. Furthermore, there have been two sudden cardiac deaths in young people aged under 35Â years, one where hypertrophic cardiomyopathy was known, and one in which no cause was identified at post-mortem. Heart transplantation for end-stage heart failure has occurred in one individual, presumably due to âburnt-outâ hypertrophic cardiomyopathy.</p>
      <p>While phenotypic heterogeneity and incomplete penetrance are common features of inherited cardiac diseases, it is unclear how divergent cardiac phenotypes emerge from the same mutation, and so exemplified by the structural and arrhythmogenic pathologies caused by the Ala119Thr mutation in <italic>ACTN2</italic>. The ACTN2 protein primarily functions to anchor and crosslink actin filaments in the cardiac Z-disc at the lateral boundaries of the sarcomere [<xref ref-type="bibr" rid="CR15">15</xref>]. The Z-disc provides structural support, by tethering the sarcomere to the sarcolemma via the costameres, and by anchoring filamentous F-actin, titin and nebulette [<xref ref-type="bibr" rid="CR16">16</xref>]. Depletion of <italic>actn2</italic> expression in zebrafish embryos, using antisense oligomers, results in a disruption of the lateral alignment of discs [<xref ref-type="bibr" rid="CR17">17</xref>]. In humans, analysis of a missense and nonsense mutation in the ACTN2 interacting protein myopalladin [<xref ref-type="bibr" rid="CR18">18</xref>], revealed a mutation dependent disruption to myofibrillogenesis, or abnormal assembly of terminal Z-discs [<xref ref-type="bibr" rid="CR19">19</xref>]. Therefore, ACTN2 and the Z-disc can be regarded as a scaffold. Additionally, the Z-disc serves as an interaction platform for proteins that shuttle to the nucleus, such as calcineurin, ankyrin repeat domain 2 and cardiac ankyrin repeat protein, and they may represent molecular messengers that translate mechanical stress into a transcriptional response [<xref ref-type="bibr" rid="CR20">20</xref>-<xref ref-type="bibr" rid="CR23">23</xref>]. Therefore the Z-disc can also be regarded as a signalling network that is well positioned to sense mechanical stress [<xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <p>Furthermore, there is evidence of ACTN2 directly interacting with cardiac ion channels, such as the potassium ion channels <italic>KCNA4</italic> and <italic>KCNA5</italic> [<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref>], the sodium ion channel <italic>SCN5A</italic> [<xref ref-type="bibr" rid="CR27">27</xref>], and it forms a bridge between the calcium ion channels <italic>CACNA1C</italic> and <italic>CACNA1D</italic> [<xref ref-type="bibr" rid="CR28">28</xref>]. Thus, disruption of ACTN2 may impact on the localisation and function of cardiac ion-channels. It is tempting to speculate that the different clinical presentations of Ala119Thr result from a stochastic disruption to one of the many functional roles of ACTN2 (FigureÂ <xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Figure 5</label><caption><p>
<bold>Alpha-actinin2 and cardiac disease.</bold> Potential mechanisms by which mutations in the <italic>ACTN2</italic> gene can lead to diverse cardiac phenotypes.</p></caption><graphic xlink:href="12881_2014_99_Fig5_HTML" id="MO5"/></fig></p>
      <p>The precedent of mutations in a single gene leading to diverse clinical phenotypes has been documented in other settings. Most notably, mutations in the lamin A/C (<italic>LMNA</italic>) gene have been identified in a diverse range of clinical phenotypes. Originally described in Emery Dreifuss muscular dystrophy, mutations in the lamin A/C gene have now been identified in a number of other diverse diseases including familial dilated cardiomyopathies with conduction disease, limb girdle muscular dystrophies, lipodystrophies, Hutchinson-Gilford progeria syndrome, and mandibuloacral dysplasia, collectively called the âlaminopathiesâ [<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR30">30</xref>]. Like the multifaceted role of lamins, and their impact on various biological signalling pathways and functions, the ACTN2 protein has similar diversity in its potential mechanistic roles (FigureÂ <xref rid="Fig5" ref-type="fig">5</xref>), and may contribute to a collection of these diseases as âZ-discopathiesâ.</p>
      <p>The current study highlights the emerging role of exome sequencing in the identification of a causative gene mutation. The traditional approach of using the clinical phenotype to select the appropriative genetic testing panel would have required consideration of a cardiomyopathy, sudden death, or arrhythmogenic gene panel, based on the diverse phenotype of the family. <italic>ACTN2</italic> is unlikely to be included on an arrhythmogenic gene diagnostic panel or a common cardiomyopathy gene panel in which each gene is responsible for &gt;5% of disease. However, <italic>ACTN2</italic> may be included on comprehensive cardiomyopathy gene panel that includes minor disease-associated genes. Exome sequencing to investigate the genetic basis of disease in this family was non-biased, robust, and comprehensive, and provided the broadest coverage of possible disease genes to facilitate the identification of the causative mutation. A number of studies have recently emerged demonstrating the use of exome sequencing in genetic discoveries in both primary arrhythmogenic disorders and inherited cardiomyopathies, and therefore provides an exciting new approach to disease gene discovery in cardiovascular disease [<xref ref-type="bibr" rid="CR31">31</xref>-<xref ref-type="bibr" rid="CR34">34</xref>].</p>
    </sec>
    <sec id="Sec12" sec-type="conclusion">
      <title>Conclusions</title>
      <p>Cardiac phenotype heterogeneity is a clinical challenge within families with inherited heart disease. Understanding the underlying genetic causes has major implications both in the diagnosis and screening of at-risk family members, and in shedding light on the mechanisms that underpin disease pathogenesis. The mutation identified in the <italic>ACTN2</italic> gene is likely ancestral to both ALB and EI families and is responsible for the marked cardiac phenotype heterogeneity observed in family members, including both structural and arrhythmogenic abnormalities, including sudden death. The diverse mechanistic roles of ACTN2 in the cardiac Z-disc may explain this heterogeneous clinical presentation. The newer approach of exome sequencing is a useful adjunct to cardiac genetic testing in families with mixed clinical presentations.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec13">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="12881_2014_99_MOESM1_ESM.xlsx" id="MOESM1">
              <label>Additional file 1: Table S1.</label>
              <caption>
                <p>Primer sequences, and PCR amplification conditions for microsatellite markers.</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12881_2014_99_MOESM2_ESM.xlsx" id="MOESM2">
              <label>Additional file 2: Table S2.</label>
              <caption>
                <p>Rare single nucleotide missense, splice site and nonsense variants.</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12881_2014_99_MOESM3_ESM.xlsx" id="MOESM3">
              <label>Additional file 3: Table S3.</label>
              <caption>
                <p>Rare insertions and deletions.</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>BrS</term>
            <def>
              <p>Brugada syndrome</p>
            </def>
          </def-item>
          <def-item>
            <term>DCM</term>
            <def>
              <p>Dilated cardiomyopathy</p>
            </def>
          </def-item>
          <def-item>
            <term>HCM</term>
            <def>
              <p>Hypertrophic cardiomyopathy</p>
            </def>
          </def-item>
          <def-item>
            <term>LQTS</term>
            <def>
              <p>Long QT syndrome</p>
            </def>
          </def-item>
          <def-item>
            <term>LVNC</term>
            <def>
              <p>Left ventricular non-compaction</p>
            </def>
          </def-item>
          <def-item>
            <term>SQTS</term>
            <def>
              <p>Short QT syndrome</p>
            </def>
          </def-item>
          <def-item>
            <term>IVF</term>
            <def>
              <p>Idiopathic ventricular fibrillation</p>
            </def>
          </def-item>
          <def-item>
            <term>SNV</term>
            <def>
              <p>Single nucleotide variation</p>
            </def>
          </def-item>
          <def-item>
            <term>ICD</term>
            <def>
              <p>Implantable cardioverter defibrillator</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authorsâ contributions</bold>
        </p>
        <p>RDB contributed to study design, acquisition of data, analysis and interpretation of data and drafting the manuscript. LKM and JMK contributed to acquisition of data and drafting the manuscript. CS contributed to study design, acquisition of data, analysis and interpretation of data and drafting the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>CS is the recipient of a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (#571084). This study was also supported, in part, by an NHMRC project grant (#632575).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilde</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Behr</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
          <article-title>Genetic testing for inherited cardiac disease</article-title>
          <source>Nat Rev Cardiol</source>
          <year>2013</year>
          <volume>10</volume>
          <issue>10</issue>
          <fpage>571</fpage>
          <lpage>583</lpage>
          <pub-id pub-id-type="doi">10.1038/nrcardio.2013.108</pub-id>
          <?supplied-pmid 23900354?>
          <pub-id pub-id-type="pmid">23900354</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maron</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Maron</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Semsarian</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Genetics of hypertrophic cardiomyopathy after 20Â years: clinical perspectives</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2012</year>
          <volume>60</volume>
          <issue>8</issue>
          <fpage>705</fpage>
          <lpage>715</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2012.02.068</pub-id>
          <?supplied-pmid 22796258?>
          <pub-id pub-id-type="pmid">22796258</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geisterfer-Lowrance</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Kass</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanigawa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vosberg</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Seidman</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Seidman</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation</article-title>
          <source>Cell</source>
          <year>1990</year>
          <volume>62</volume>
          <issue>5</issue>
          <fpage>999</fpage>
          <lpage>1006</lpage>
          <pub-id pub-id-type="doi">10.1016/0092-8674(90)90274-I</pub-id>
          <?supplied-pmid 1975517?>
          <pub-id pub-id-type="pmid">1975517</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karam</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Raboisson</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Ducreux</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chalabreysse</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Millat</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bozio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bouvagnet</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy</article-title>
          <source>Congenit Heart Dis</source>
          <year>2008</year>
          <volume>3</volume>
          <issue>2</issue>
          <fpage>138</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1747-0803.2008.00165.x</pub-id>
          <?supplied-pmid 18380764?>
          <pub-id pub-id-type="pmid">18380764</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Villard</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Duboscq-Bidot</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Charron</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Benaiche</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Conraads</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sylvius</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Komajda</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene</article-title>
          <source>Eur Heart J</source>
          <year>2005</year>
          <volume>26</volume>
          <issue>8</issue>
          <fpage>794</fpage>
          <lpage>803</lpage>
          <pub-id pub-id-type="doi">10.1093/eurheartj/ehi193</pub-id>
          <?supplied-pmid 15769782?>
          <pub-id pub-id-type="pmid">15769782</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Kirsch</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Potenza</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Borggrefe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Breithardt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ortiz-Lopez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Antzelevitch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Schulze-Bahr</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Keating</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Towbin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>Genetic basis and molecular mechanism for idiopathic ventricular fibrillation</article-title>
          <source>Nature</source>
          <year>1998</year>
          <volume>392</volume>
          <issue>6673</issue>
          <fpage>293</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="doi">10.1038/32675</pub-id>
          <?supplied-pmid 9521325?>
          <pub-id pub-id-type="pmid">9521325</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Splawski</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Atkinson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Towbin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Keating</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome</article-title>
          <source>Cell</source>
          <year>1995</year>
          <volume>80</volume>
          <issue>5</issue>
          <fpage>805</fpage>
          <lpage>811</lpage>
          <pub-id pub-id-type="doi">10.1016/0092-8674(95)90359-3</pub-id>
          <?supplied-pmid 7889574?>
          <pub-id pub-id-type="pmid">7889574</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ackerman</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Priori</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Willems</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Berul</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Calkins</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Camm</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Ellinor</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Gollob</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hershberger</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Judge</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Le Marec</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Schulze-Bahr</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Semsarian</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Towbin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wilde</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wolpert</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zipes</surname>
              <given-names>DP</given-names>
            </name>
            <collab>Heart Rhythm Society (HRS); European Heart Rhythm Association (EHRA)</collab>
          </person-group>
          <article-title>HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)</article-title>
          <source>Europace</source>
          <year>2011</year>
          <volume>13</volume>
          <issue>8</issue>
          <fpage>1077</fpage>
          <lpage>1109</lpage>
          <pub-id pub-id-type="doi">10.1093/europace/eur245</pub-id>
          <?supplied-pmid 21810866?>
          <pub-id pub-id-type="pmid">21810866</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meder</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heid</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Just</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Borries</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boisguerin</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Scharfenberger-Schmeer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stahler</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Beier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weichenhan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Strom</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Pfeufer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Korn</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Katus</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Rottbauer</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies</article-title>
          <source>Circ Cardiovasc Genet</source>
          <year>2011</year>
          <volume>4</volume>
          <issue>2</issue>
          <fpage>110</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.110.958322</pub-id>
          <?supplied-pmid 21252143?>
          <pub-id pub-id-type="pmid">21252143</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Muzny</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Reid</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Bainbridge</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Willis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Braxton</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beuten</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Hardison</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Person</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bekheirnia</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Leduc</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Kirby</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pham</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Scull</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Plon</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Lupski</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Beaudet</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Gibbs</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Eng</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders</article-title>
          <source>N Engl J Med</source>
          <year>2013</year>
          <volume>369</volume>
          <issue>16</issue>
          <fpage>1502</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa1306555</pub-id>
          <?supplied-pmid 24088041?>
          <pub-id pub-id-type="pmid">24088041</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <issue>5</issue>
          <fpage>589</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp698</pub-id>
          <?supplied-pmid 20080505?>
          <pub-id pub-id-type="pmid">20080505</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Handsaker</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wysoker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fennell</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Homer</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marth</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Abecasis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The Sequence Alignment/Map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <issue>16</issue>
          <fpage>2078</fpage>
          <lpage>2079</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
          <?supplied-pmid 19505943?>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKenna</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sivachenko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cibulskis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kernytsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Garimella</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Altshuler</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>DePristo</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
          <source>Genome Res</source>
          <year>2010</year>
          <volume>20</volume>
          <issue>9</issue>
          <fpage>1297</fpage>
          <lpage>1303</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
          <?supplied-pmid 20644199?>
          <pub-id pub-id-type="pmid">20644199</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bagnall</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Ingles</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yeates</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kennerson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Donald</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Jormakka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lind</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Semsarian</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2010</year>
          <volume>55</volume>
          <issue>11</issue>
          <fpage>1127</fpage>
          <lpage>1135</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2009.11.016</pub-id>
          <?supplied-pmid 20022194?>
          <pub-id pub-id-type="pmid">20022194</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sjoblom</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Salmazo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Djinovic-Carugo</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Alpha-actinin structure and regulation</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2008</year>
          <volume>65</volume>
          <issue>17</issue>
          <fpage>2688</fpage>
          <lpage>2701</lpage>
          <pub-id pub-id-type="doi">10.1007/s00018-008-8080-8</pub-id>
          <?supplied-pmid 18488141?>
          <pub-id pub-id-type="pmid">18488141</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luther</surname>
              <given-names>PK</given-names>
            </name>
          </person-group>
          <article-title>The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling</article-title>
          <source>J Muscle Res Cell Motil</source>
          <year>2009</year>
          <volume>30</volume>
          <issue>5â6</issue>
          <fpage>171</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="doi">10.1007/s10974-009-9189-6</pub-id>
          <?supplied-pmid 19830582?>
          <pub-id pub-id-type="pmid">19830582</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>alpha-Actinin2 is required for the lateral alignment of Z discs and ventricular chamber enlargement during zebrafish cardiogenesis</article-title>
          <source>FASEB J</source>
          <year>2012</year>
          <volume>26</volume>
          <issue>10</issue>
          <fpage>4230</fpage>
          <lpage>4242</lpage>
          <pub-id pub-id-type="doi">10.1096/fj.12-207969</pub-id>
          <?supplied-pmid 22767232?>
          <pub-id pub-id-type="pmid">22767232</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bang</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Mudry</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>McElhinny</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Trombitas</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Geach</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Yamasaki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sorimachi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Granzier</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gregorio</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Labeit</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies</article-title>
          <source>J Cell Biol</source>
          <year>2001</year>
          <volume>153</volume>
          <issue>2</issue>
          <fpage>413</fpage>
          <lpage>427</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.153.2.413</pub-id>
          <?supplied-pmid 11309420?>
          <pub-id pub-id-type="pmid">11309420</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Purevjav</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Arimura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Augustin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Huby</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nunoda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kearney</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Terasaki</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bos</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ommen</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Shibata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Itoh-Satoh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Labeit</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamanaka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Machida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Weintraub</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Kitaura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ackerman</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Towbin</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations</article-title>
          <source>Hum Mol Genet</source>
          <year>2012</year>
          <volume>21</volume>
          <issue>9</issue>
          <fpage>2039</fpage>
          <lpage>2053</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/dds022</pub-id>
          <?supplied-pmid 22286171?>
          <pub-id pub-id-type="pmid">22286171</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frank</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kuhn</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Katus</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>The sarcomeric Z-disc: a nodal point in signalling and disease</article-title>
          <source>J Mol Med (Berl)</source>
          <year>2006</year>
          <volume>84</volume>
          <issue>6</issue>
          <fpage>446</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="doi">10.1007/s00109-005-0033-1</pub-id>
          <pub-id pub-id-type="pmid">16416311</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frey</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>EN</given-names>
            </name>
          </person-group>
          <article-title>Calsarcins, a novel family of sarcomeric calcineurin-binding proteins</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2000</year>
          <volume>97</volume>
          <issue>26</issue>
          <fpage>14632</fpage>
          <lpage>14637</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.260501097</pub-id>
          <?supplied-pmid 11114196?>
          <pub-id pub-id-type="pmid">11114196</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kojic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Medeot</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Guccione</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Krmac</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zara</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Faulkner</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle</article-title>
          <source>J Mol Biol</source>
          <year>2004</year>
          <volume>339</volume>
          <issue>2</issue>
          <fpage>313</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2004.03.071</pub-id>
          <?supplied-pmid 15136035?>
          <pub-id pub-id-type="pmid">15136035</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway</article-title>
          <source>Development</source>
          <year>1997</year>
          <volume>124</volume>
          <issue>4</issue>
          <fpage>793</fpage>
          <lpage>804</lpage>
          <?supplied-pmid 9043061?>
          <pub-id pub-id-type="pmid">9043061</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frank</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Cardiac Z-disc signaling network</article-title>
          <source>J Biol Chem</source>
          <year>2011</year>
          <volume>286</volume>
          <issue>12</issue>
          <fpage>9897</fpage>
          <lpage>9904</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.R110.174268</pub-id>
          <?supplied-pmid 21257757?>
          <pub-id pub-id-type="pmid">21257757</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cukovic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Wible</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Steele</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Fedida</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>A discrete amino terminal domain of Kv1.5 and Kv1.4 potassium channels interacts with the spectrin repeats of alpha-actinin-2</article-title>
          <source>FEBS Lett</source>
          <year>2001</year>
          <volume>498</volume>
          <issue>1</issue>
          <fpage>87</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-5793(01)02505-4</pub-id>
          <?supplied-pmid 11389904?>
          <pub-id pub-id-type="pmid">11389904</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maruoka</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Steele</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Au</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Dan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Fedida</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>alpha-actinin-2 couples to cardiac Kv1.5 channels, regulating current density and channel localization in HEK cells</article-title>
          <source>FEBS Lett</source>
          <year>2000</year>
          <volume>473</volume>
          <issue>2</issue>
          <fpage>188</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-5793(00)01521-0</pub-id>
          <?supplied-pmid 10812072?>
          <pub-id pub-id-type="pmid">10812072</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziane</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Moghadaszadeh</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Beggs</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Levesque</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chahine</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cell membrane expression of cardiac sodium channel Na(v)1.5 is modulated by alpha-actinin-2 interaction</article-title>
          <source>Biochemistry</source>
          <year>2010</year>
          <volume>49</volume>
          <issue>1</issue>
          <fpage>166</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="doi">10.1021/bi901086v</pub-id>
          <?supplied-pmid 19943616?>
          <pub-id pub-id-type="pmid">19943616</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Timofeyev</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Knowlton</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Chiamvimonvat</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Molecular coupling of a Ca2â+ââactivated Kâ+âchannel to L-type Ca2+ channels via alpha-actinin2</article-title>
          <source>Circ Res</source>
          <year>2007</year>
          <volume>100</volume>
          <issue>1</issue>
          <fpage>112</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.0000253095.44186.72</pub-id>
          <?supplied-pmid 17110593?>
          <pub-id pub-id-type="pmid">17110593</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Worman</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Nuclear lamins and laminopathies</article-title>
          <source>J Pathol</source>
          <year>2012</year>
          <volume>226</volume>
          <issue>2</issue>
          <fpage>316</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="doi">10.1002/path.2999</pub-id>
          <?supplied-pmid 21953297?>
          <pub-id pub-id-type="pmid">21953297</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schreiber</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>BK</given-names>
            </name>
          </person-group>
          <article-title>When lamins go bad: nuclear structure and disease</article-title>
          <source>Cell</source>
          <year>2013</year>
          <volume>152</volume>
          <issue>6</issue>
          <fpage>1365</fpage>
          <lpage>1375</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2013.02.015</pub-id>
          <?supplied-pmid 23498943?>
          <pub-id pub-id-type="pmid">23498943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marsman</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Barc</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Beekman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Alders</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dooijes</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Van-den-Wijngaard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ratbi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sefiani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bhuiyan</surname>
              <given-names>ZA</given-names>
            </name>
            <name>
              <surname>Wilde</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Bezzina</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2013</year>
          <volume>63</volume>
          <issue>3</issue>
          <fpage>259</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2013.07.091</pub-id>
          <?supplied-pmid 24076290?>
          <pub-id pub-id-type="pmid">24076290</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crotti</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Graf</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Ferrari</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Cuneo</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Ovadia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Papagiannis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Feldkamp</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Rathi</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Kunic</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Pedrazzini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wieland</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lichtner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Beckmann</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shaffer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Benson</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>KÃ¤Ã¤b</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meitinger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Strom</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Chazin</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>AL</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Calmodulin mutations associated with recurrent cardiac arrest in infants</article-title>
          <source>Circulation</source>
          <year>2013</year>
          <volume>127</volume>
          <issue>9</issue>
          <fpage>1009</fpage>
          <lpage>1017</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.001216</pub-id>
          <?supplied-pmid 23388215?>
          <pub-id pub-id-type="pmid">23388215</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rampersaud</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Morales</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Zuchner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hedges</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Krumm</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nickerson</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Hershberger</surname>
              <given-names>RE</given-names>
            </name>
            <collab>National Heart, Lung, and Blood Institute GO Exome Sequencing Project and the Exome Sequencing Project Family Studies Project Team</collab>
          </person-group>
          <article-title>Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy</article-title>
          <source>Circ Cardiovasc Genet</source>
          <year>2013</year>
          <volume>6</volume>
          <issue>2</issue>
          <fpage>144</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.111.000062</pub-id>
          <?supplied-pmid 23418287?>
          <pub-id pub-id-type="pmid">23418287</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rieder</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Siegfried</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Rampersaud</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zuchner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mangos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gonzalez-Quintana</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>McGee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reiser</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nickerson</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Hershberger</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy</article-title>
          <source>Am J Hum Genet</source>
          <year>2011</year>
          <volume>88</volume>
          <issue>3</issue>
          <fpage>273</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.01.016</pub-id>
          <?supplied-pmid 21353195?>
          <pub-id pub-id-type="pmid">21353195</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>